title: Acute Pisa syndrome after administration of a single dose of mirtazapine.
abstract: Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.
authors.affiliation: Department of Neurology, 12 de Octubre University Hospital, Madrid, Spain. mendezguerrero.antonio@gmail.com
authors.forename: Antonio
authors.initials: A
authors.lastname: Méndez Guerrero
authors.forename: Sara
authors.initials: S
authors.lastname: Llamas
authors.forename: Francisco José
authors.initials: FJ
authors.lastname: Murcia
authors.forename: Juan
authors.initials: J
authors.lastname: Ruíz
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D004421:Dystonia / Q000209:etiology*; D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D009333:Neck; D012720:Severity of Illness Index; D060726:Torso
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine